Xinan Sheng, Cuijian Zhang, Yongpeng Ji, Li Zhou, Benkui Zou, Hang Huang, Yonghua Wang, Kaiwei Yang, Xue Bai, Dan Feng, Yong Yang, Jiasheng Bian, Zhixian Yu, Haitao Niu, Peng Du, Jianmin Fang, Zhisong He, Jun Guo. "Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the phase II RC48-C017 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.665